|
MAP1LC3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.223050E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.964500E-02 |
| Normal-vs-Stage2 |
2.926200E-01 |
| Normal-vs-Stage3 |
3.66529999999976E-05 |
| Normal-vs-Stage4 |
1.808130E-04 |
| Stage1-vs-Stage2 |
5.373000E-01 |
| Stage1-vs-Stage3 |
3.497300E-03 |
| Stage1-vs-Stage4 |
2.672100E-02 |
| Stage2-vs-Stage3 |
1.442150E-02 |
| Stage2-vs-Stage4 |
4.816100E-02 |
| Stage3-vs-Stage4 |
7.273800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.381200E-03 |
| Normal-vs-AfricanAmerican |
1.399600E-04 |
| Normal-vs-Asian |
5.914800E-01 |
| Caucasian-vs-AfricanAmerican |
4.475900E-02 |
| Caucasian-vs-Asian |
9.432000E-01 |
| AfricanAmerican-vs-Asian |
6.089000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.936400E-03 |
| Normal-vs-Female |
1.201830E-03 |
| Male-vs-Female |
9.259000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.163700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.359700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.54690000000657E-05 |
| Normal-vs-Age(81-100Yrs) |
5.547900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.489000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.425600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.460300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.064200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.827600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.617200E-01 |
| Normal-vs-Grade 2 |
6.183800E-02 |
| Normal-vs-Grade 3 |
4.2878000000024E-05 |
| Normal-vs-Grade 4 |
6.32839999999968E-05 |
| Grade 1-vs-Grade 2 |
7.439000E-01 |
| Grade 1-vs-Grade 3 |
1.581800E-01 |
| Grade 1-vs-Grade 4 |
9.425600E-02 |
| Grade 2-vs-Grade 3 |
3.958600E-03 |
| Grade 2-vs-Grade 4 |
4.543700E-03 |
| Grade 3-vs-Grade 4 |
3.853800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.145600E-02 |
| Normal-vs-ccB subtype |
2.168000E-02 |
| ccA subtype-vs-ccB subtype |
4.074600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.448030E-02 |
| Normal-vs-N1 |
1.251690E-02 |
| N0-vs-N1 |
2.481600E-01 |
|
|
